Authors


Kate Gainer, PharmD

Latest:

My Burnout Story

I am grateful to those who identified my burnout and supported me to make changes and reverse the syndrome.


Ronnie DePue, RPh, CGP

Latest:

MTM Spotlights Pharmacy's Patient Counseling Role

Pharmacists are in the perfect position to influence patients and improve outcomes with medication therapy management.


Daniela E. Myers, MPH

Latest:

Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin

Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.


Caryn Domenici Belisle, RPh, Alka Patel, PharmD

Latest:

Takeda Pharmaceuticals America, Inc's Edarbi

The FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.


Alexander Kantorovich, PharmD, BCPS

Latest:

Which Left Ventricular Assist Device Is Best?

Advanced heart failure leads to significant limitations, affecting functional status, quality of life, and survival, despite optimal medical treatment with evidence-based therapies.


Quintin Jessee, RPh, DPh

Latest:

Changes Coming in Specialty Pharmacy Accreditation

If you're not accredited with any of the major players, you could instantly lose out on future business growth opportunities.


F. Thomas Kaplan, MD

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Jean Chang, BS

Latest:

Telephone-Based Cardiovascular Medication Therapy Management in Medicare Part D Enrollees With Diabetes

A telephonic pharmacist-delivered medication therapy management intervention is an effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk Medicare patients with diabetes.


Michael C. Wisotsky, PharmD, RPh

Latest:

Hepatitis C

Achieving a sustained viral response in patients with hepatitis C is showed to reduce the risk of liver cancer.


Michael S. Kirkbride, PharmD, Option Care Health, vice president of Specialty

Latest:

Infusion Pharmacist Expertise Vital in Helping Manage IG Shortages, Ensuring Right Drug Gets to the Right Patient at the Right Dose

Perceived as the new “wonder drug,” immunoglobulin (IG) is a go-to therapy for healthcare providers seeking to bolster their patients’ immune systems; however, as demand grows, particularly for oncology and off-label indications, the supply can’t keep pace.


Maura McGuire, MD

Latest:

Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty Practice

While warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.


Sarah Scoular, PharmD, BCPS

Latest:

Sustainable Health Care in Developing Nations

Sarah Scoular, PharmD, BCPS, assistant professor at the University of Colorado Skaggs School of Pharmacy, discusses some of the international work she has been involved in.


Ryan Stept, MSc

Latest:

Specialty Pharmacy: A Five-Pronged Approach to Managing Cost

Specialty pharmacy is beginning to implement its own set of strategies in order to manage the cost of one of the most expensive sectors of the pharmaceutical industry.



NABP

Latest:

General Availability for .Pharmacy Domain Names Begins June 3, 2015

The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.



Eric S. Rovner, MD

Latest:

Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder

In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.


Geneviève Gauthier, MSc

Latest:

Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic Therapies

Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.


Jennifer M. Lose, PharmD, BCPS

Latest:

Utility of Antithrombotic Therapy in Chronic Systolic Heart Failure

The primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.


Larry Sweeney, Chief Operating Officer at DDN

Latest:

Supply Chain Innovations

Complex distribution challenges for manufacturers of specialty drugs require life science and cold chain experts to provide a faster, better way of distributing these life-saving medications.



Erin Hulbert, MS

Latest:

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.


Qayyim Said, PhD

Latest:

Self-Reported Plan Switching in Medicare Part D: 2006-2010

Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.


Ronnie Stotts, BS

Latest:

Psoriasis Treatment Cost Comparison: Biologics Versus Home Phototherapy

An estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.



Matthew Sussman, MA

Latest:

Resource Use Among Nonvalvular Atrial Fibrillation Patients

This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.


Jennifer L. Hofmann, DMSC, MS, PA-C

Latest:

Clinicians, Pharmacists Should Work to Ensure Safety Compounded GLP-1 Medications

Pharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.



T. Mitchell James, III

Latest:

Not Just a Generic: Specialty Pharmacy Considerations for a Biosimilar Launch

As new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.